Skip to main content
OpenTrials
Completed

NCT Number: NCT04089644

Manual vs Closed-loop Control of Mean Arterial Pressure

Intraoperative hypotension can impact patient outcome. Vasopressors are usually used to correct hypotension and ensure adequate organ perfusion.

The investigators have recently developed an automated system (closed-loop system) to titrate vasopressor agents in surgical and intensive care patients.

The purpose of this study is to compare two strategies to correct hypotension based on an individual definition of hypotension (therefore, the target MAP used to define hypotension will differ for each patient (individualized approach):

1. Control group = standard practice ( manually adjusted norepinephrine infusion to correct hypotension and keep MAP within 90% of patient's baseline MAP 2. Intervention group = closed-loop (automated) vasopressor administration system will deliver norepinephrine using feedback from standard operating room hemodynamic monitor (EV1000 Monitor-Flotrac, Edwards Lifesciences, IRVINE, USA) to correct hypotension and keep MAP within 90% of patient's baseline MAP

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–99 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Erasme Hospital

Brussels, Brussel-hoofdstad, 1070, Belgium

About this study

In order to prevent the known postoperative complications of intraoperative hypotension, vasopressor agents are occasionally used to ensure adequate perfusion. These vasopressors are usually administered as manually adjusted infusions, but this practice requires considerable time and attention.

To overcome this issue, the investigators have developed a closed-loop vasopressor (CLV) controller to potentially correct hypotension more efficiently. After completing extensive in-silico, in-vivo studies and a pilot human trial in a small cohort of 20 patients, the investigators aimed to conduct now a randomized control trial comparing manual vasopressor adjustment versus closed-loop vasopressor adjustment in high risk patients undergoing major abdominal surgeries in order to correct hypotension during surgery

The primary outcome will be the incidence of hypotension (defined as a reduction of > 10% from patient's MAP target, or a allowed tolerance of 10% reduction from patient's baseline MAP). This has been chosen based on the recent study of Emmanuel Futier and colleagues (Effect of Individualized vs Standard Blood Pressure Management Strategies on Postoperative Organ Dysfunction Among High-Risk Patients Undergoing Major Surgery: A Randomized Clinical Trial. JAMA. 2017 Oct 10;318(14):1346-1357), even if it was originally done with systolic blood pressure

Participants in both groups will receive standard patient care in that in no way will their anesthetic or surgical procedure will be altered as part of the study, with the exception of vasopressor administration.

Fluids will be standardized in both groups and will be given as a continuous baseline infusion of 3 ml/kg/h (balanced crystalloid solution) and additional fluid boluses (mini fluid challenges of 100 ml) as a goal directed fluid therapy strategy to maintain stroke volume variation < 13%. The only difference is the way norepinephrine is delivered to the patient (manual versus closed-loop assisted)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • High-risk adult patients undergoing major abdominal surgeries requiring an advanced cardiac output monitoring device (EV1000-Edwards LifeSciences, Irvine, USA) and a tight blood pressure control

Exclusion criteria

  • Atrial Fibrillation
  • Severe Arythmia

Treatment and study plan

Closed-loop system

Device

Hypotension will be corrected by an automated system for vasopressor administration.

Fluids will be given using a goal directed strategy (EV1000 Monitor, Edwards Lifesciences, Irvine, CA, USA)

Manual adjustment

Device

Vasopressor agents will be manually adjusted (standard practice).

Fluids will be given using a goal directed strategy (EV1000 Monitor, Edwards Lifesciences, Irvine, CA, USA)

Primary outcomes

  1. Percentage of case Time in hypotension (MAP < 90% of the chosen MAP target).

    Time frame: At postoperative day 1

    Undertreatment. Percentage of time during surgery in hypotension. The MAP used to define hypotension will differ for each patient (individualized approach)

Secondary outcomes

  1. Percentage of case time in hypotension (MAP < 65 mmHg)

    Time frame: during surgery

    Percentage of time during surgery in hypotension using the population target usually admitted and used in clinical studies (MAP < 65 mmHg)

  2. Percentage of case time in target (MAP +/- 10 mmHg) of the chosen MAP target

    Time frame: during surgery

    Percentage of time during surgery with a MAP +/- 10 mmHg of the chosen MAP target.

  3. Amount of vasopressors received

    Time frame: during surgery

    Amount of vasopressors received

  4. Uretral perfusion index during surgery

    Time frame: during surgery

    Mean Uretral perfusion index during surgery using the novel IKORUS urinary catheter recently available on the market

  5. Uretral perfusion index during the first 15 minutes of the surgery

    Time frame: during surgery

    Mean Uretral perfusion index during the first 15 minutes of the surgery

  6. Uretral perfusion index during the last 15 minutes of the surgery

    Time frame: during surgery

    Mean Uretral perfusion index during the last 15 minutes of the surgery

  7. Cardiac index during surgery

    Time frame: during surgery

    Mean cardiac index during surgery

  8. Stroke volume index during surgery

    Time frame: during surgery

    Mean Stroke volume index during surgery

  9. Stroke volume variation during surgery

    Time frame: during surgery

    Mean Stroke volume variation during surgery

  10. Amount of fluid received during surgery

    Time frame: during surgery

    Amount of fluid received during surgery

  11. Net fluid balance during surgery

    Time frame: during surgery

    Net fluid balance during surgery

Sponsors and collaborators

Lead sponsor

Erasme University Hospital

Other

Collaborators

  • Bicetre Hospital
  • University of California, Irvine
  • University of California, Los Angeles

Registry information

Official study title

Physician-Directed vs Computer-Assisted Norepinephrine Administration in Patients Undergoing Major Abdominal Surgery: A Randomized Controlled Trial

Important dates

Study start
2019
Primary completion
2020
Study completion
2020
First posted
Sep 13, 2019
Registry last updated
Mar 10, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.